September 2019
- Angiotensin Receptor–Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
- Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
- Association of Optimal Blood Pressure With Critical Cardiorenal Events and Mortality in High-Risk and Low-Risk Patients Treated With Antihypertension Medications
- Cognitive decline association with small and large infarctions
- Redefining Heart Failure With a Reduced Ejection Fraction